THE LATINO CANCER INSTITUTE Trademark
Trademark Overview
On Tuesday, October 21, 2025, a trademark application was filed for THE LATINO CANCER INSTITUTE with the United States Patent and Trademark Office. The USPTO has given the THE LATINO CANCER INSTITUTE trademark a serial number of 99454306. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, October 21, 2025. This trademark is owned by Ysabel Duron. The THE LATINO CANCER INSTITUTE trademark is filed in the Advertising, Business and Retail Services category with the following description:
Association services, namely, promoting the public interest and awareness in cancer research and education; Promoting public interest and awareness of Latinos with cancer. Was presidentially appointed (2023-Biden) to the National Cancer Advisory Board ( NCI), where Latino concerns are shared; presented to the Latino Congressional Caucus (2024) on Latino cancer issues and systemic barriers; keynoted at the American Association of Cancer Researchers (AACR) Baltimore Disparities Conference (2025); currently serves on the California Institute for Regenerative Medicine (CIRM), a taxpayer funded stem cell agency as a patient advocate.; Promoting collaboration within the scientific, research and provider communities to achieve advances in the field of cancer risk, diagnostics and treatment. To that end, TLCI is engaged in research with Stanford University's School of Medicine (liver disease study); UCSF and UC Davis (developing and deploying a breast cancer hereditary toolkit with FQHC's), Ge...

General Information
| Serial Number | 99454306 |
| Word Mark | THE LATINO CANCER INSTITUTE |
| Filing Date | Tuesday, October 21, 2025 |
| Status | 630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER |
| Status Date | Tuesday, October 21, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Association services, namely, promoting the public interest and awareness in cancer research and education; Promoting public interest and awareness of Latinos with cancer. Was presidentially appointed (2023-Biden) to the National Cancer Advisory Board ( NCI), where Latino concerns are shared; presented to the Latino Congressional Caucus (2024) on Latino cancer issues and systemic barriers; keynoted at the American Association of Cancer Researchers (AACR) Baltimore Disparities Conference (2025); currently serves on the California Institute for Regenerative Medicine (CIRM), a taxpayer funded stem cell agency as a patient advocate.; Promoting collaboration within the scientific, research and provider communities to achieve advances in the field of cancer risk, diagnostics and treatment. To that end, TLCI is engaged in research with Stanford University's School of Medicine (liver disease study); UCSF and UC Davis (developing and deploying a breast cancer hereditary toolkit with FQHC's), Georgetown (psychosocial support for breast cancer patients and their caregivers increasing patient quality care experience); Duke University (AI); a community engagement project with the Universities of New Mexico and Iowa. |
Classification Information
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, October 21, 2025 |
| Primary Code | 035 |
| First Use Anywhere Date | Friday, January 5, 2018 |
| First Use In Commerce Date | Friday, January 5, 2018 |
Trademark Owner History
| Party Name | Ysabel Duron |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 54 - NOT AVAILABLE |
| Address | San Jose, CA 95112 |
Trademark Events
| Event Date | Event Description |
| Tuesday, October 21, 2025 | NEW APPLICATION ENTERED |
| Tuesday, October 21, 2025 | APPLICATION FILING RECEIPT MAILED |